Co-Authors
                                
                                
                                    This is a "connection" page, showing publications co-authored by Tom Luedde and Noemi Freise.
                                
                                
                                
                                    
                                        
                                                
    
        
        
        
            Connection Strength
            
                
            
            0.299
         
        
        
     
 
    
        
        - 
            Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany. Lancet Reg Health Eur. 2021 Sep; 8:100164.
            
            
                Score: 0.239
             
- 
            Delayed skin reaction after mRNA-1273 vaccine against SARS-CoV-2: a rare clinical reaction. Eur J Med Res. 2021 Aug 25; 26(1):98.
            
            
                Score: 0.060